The relationship between oral mucositis and levels of pro-inflammatory cytokines in serum and in gingival crevicular fluid in allogeneic stem cell recipients

[1] Sonis ST(2004)Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients Cancer 100 1995-2025

[2] Elting LS(2011)Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT—results of a multicentre study Bone Marrow Transplant 46 727-732

[3] Keefe D(2013)Emerging evidence on the pathobiology of mucositis Support Care Cancer Off J Multinatl Assoc Support Care Cancer 21 3233-3241

[4] Vagliano L(2002)Allogeneic hematopoietic stem cell transplantation: complications and results Arch Intern Med 162 1558-1566

[5] Feraut C(2009)Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia J Clin Oncol Off J Am Soc Clin Oncol 27 4570-4577

[6] Gobetto G(2005)Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives APMIS Acta Pathol Microbiol Immunol Scand 113 813-830

[7] Al-Dasooqi N(2014)Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients Support Care Cancer Off J Multinatl Assoc Support Care Cancer 22 2133-2140

[8] Sonis ST(2013)A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation J Intern Med 274 153-162

[9] Bowen JM(2004)The pathobiology of mucositis Nat Rev Cancer 4 277-284

[10] Tabbara IA(2008)Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis Cancer Chemother Pharmacol 62 33-41

[1] Sonis ST(2004)Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients Cancer 100 1995-2025

[2] Elting LS(2011)Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT—results of a multicentre study Bone Marrow Transplant 46 727-732

[3] Keefe D(2013)Emerging evidence on the pathobiology of mucositis Support Care Cancer Off J Multinatl Assoc Support Care Cancer 21 3233-3241

[4] Vagliano L(2002)Allogeneic hematopoietic stem cell transplantation: complications and results Arch Intern Med 162 1558-1566

[5] Feraut C(2009)Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia J Clin Oncol Off J Am Soc Clin Oncol 27 4570-4577

[6] Gobetto G(2005)Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives APMIS Acta Pathol Microbiol Immunol Scand 113 813-830

[7] Al-Dasooqi N(2014)Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients Support Care Cancer Off J Multinatl Assoc Support Care Cancer 22 2133-2140

[8] Sonis ST(2013)A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation J Intern Med 274 153-162

[9] Bowen JM(2004)The pathobiology of mucositis Nat Rev Cancer 4 277-284

[10] Tabbara IA(2008)Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis Cancer Chemother Pharmacol 62 33-41